Independent Director · Xenon Pharmaceuticals Inc. (XENE)

Gillian Cannon director compensation at Xenon Pharmaceuticals: $459K

Fiscal year 2025 director compensation for Gillian Cannon at Xenon Pharmaceuticals Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 22, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Gillian Cannon’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Gillian Cannon and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Xenon Pharmaceuticals Director Compensation Table · all 3 fiscal years held
In US dollars, as Xenon Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$52,890$81,281$324,752$0$458,923
FY2024$47,899—$414,333—$462,232
FY2023$17,957—$752,953—$770,910

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Xenon Pharmaceuticals Inc. DEF 14A filed April 22, 2026, accession 0001193125-26-170320, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Xenon Pharmaceuticals Inc. filed document, accession 0001193125-26-170320. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.

Get the Xenon Pharmaceuticals Board Governance Report

$458,923 Gillian Cannon, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 22, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Xenon Pharmaceuticals pays directors a $50,000 cash retainer and $440,000 in Options/RSUs.

Committees

FY2025 · as the proxy prints them

Audit

The rest of the Xenon Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Dawn SvoronosChair of the Board$498,923
Elizabeth GarofaloIndependent Director$458,923
Gary PatouIndependent Director$461,423
Ian MortimerDirector—
Justin GoverIndependent Director$478,923
Patrick MachadoIndependent Director$471,423
Steven GannonIndependent Director$473,923

The full Xenon Pharmaceuticals compensation record

free company brief

This page is one director within Xenon Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Order XENE

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report